DexCom Announces Upcoming Conference Presentations
February 24 2015 - 8:30AM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that management will
present an update on DexCom at the following upcoming investor
conferences:
- Steve Pacelli, Executive Vice
President, Strategy and Corporate Development, will present an
update on the company at the Raymond James 36th Annual
Institutional Investors Conference in Orlando, Florida on Tuesday,
March 3, 2015 at 9:15am (EST). The presentation, which will occur
live at the JW Marriott Grande Lakes, will be concurrently
webcast.
- Steve Pacelli, Executive Vice
President, Strategy and Corporate Development, will present an
update on the company at the Barclays Global Healthcare Conference
in Miami, Florida on Tuesday, March 10, 2015 at 9:30am (EDT). The
presentation, which will occur live at the Loews Miami Hotel, will
be concurrently webcast.
The link to each webcast will be available on the DexCom website
at www.dexcom.com by navigating to “Our Company,” then “Investor
Relations,” and finally “Events and Webcasts” and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is
developing and marketing continuous glucose monitoring systems for
ambulatory use by patients and by healthcare providers in the
hospital.
Cautionary Statement Regarding Forward-Looking
Statements
DexCom is a medical device company with a limited operating
history. Successful commercialization of the company's products is
subject to numerous risks and uncertainties, including a lack of
acceptance in the marketplace by physicians and patients, the
inability to manufacture products in commercial quantities at an
acceptable cost, possible delays in the company's development
programs, the inability of patients to receive reimbursement from
third-party payors and inadequate financial and other resources.
Certain of these risks and uncertainties, in addition to other
risks, are more fully described in the company's quarterly report
on Form 10-Q for the quarter ended September 30, 2014, as filed
with the Securities and Exchange Commission on November 6,
2014.
DexCom, Inc.Steven R. PacelliExecutive Vice President,
Strategy and Corporate Development858-200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Aug 2024 to Sep 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Sep 2023 to Sep 2024